Kuros Biosciences Ltd. Logo

Kuros Biosciences Ltd.

ISIN: CH0325814116 | Ticker: KURN | LEI: 5299006U5POB2AVTT709
Sector: Health CareSub-Industry: Biotechnology
Country: Switzerland

About Kuros Biosciences Ltd.

Company Description

With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we're never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Served area

Worldwide

Headcount

58

Headquarters

Wagistrasse 25, 8952 Schlieren – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
29.11.23 None Executive member Sell CHF 9,270.00

Capital markets information

ISIN

CH0325814116

LEI

5299006U5POB2AVTT709

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.